Zach Reitano
business executiveMale0.0Global Dominance: 0.00%
Zach Reitano is the CEO of Ro, a telehealth company that has gained attention for its promotion of GLP-1 weight-loss drugs such as Ozempic. He has been instrumental in shaping the company’s marketing strategies, which have included high-profile partnerships, like that with Serena Williams, aimed at normalizing the use of weight-loss medications as lifestyle choices.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Ro CEO Zach Reitano joins ‘Mornings with Maria’ to discuss the launch of the Wegovy oral pill.
Hims & Hers pulls Wegovy knockoff drug after FDA regulatory threatFox News·
United States· 2026-02-08
United States· 2026-02-08Also mentioned
Andrew Dudum
Zach Reitano, the CEO of Ro, explained why Serena Williams was chosen for their campaign promoting weight-loss drugs.
Serena Williams built her legacy on defiance. Why lend it to Ozempic culture? | Serena WilliamsThe Guardian·
United Kingdom· 2025-08-23
United Kingdom· 2025-08-23
